Grantclosed🌐 United StatesPAR-24-066

NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U44-Clinical Trial Required)

National Institutes of Health

Details?

Posted: Dec 1, 2023
Response deadline: Nov 17, 2025, 12:00 AM UTC
Type: Grant
Category: 93.867
Status: closed
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: PAR-24-066

Doc Type: synopsis
Opp Status: archived

Similar past solicitations

PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
United States · Jul 3, 2024
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
United States · Jan 29, 2024
PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
United States · Jul 3, 2024
NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
United States · Nov 12, 2024
NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)
United States · Jan 3, 2025
BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
United States · Dec 9, 2024

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.